Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
Clinical trial NCT01087554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01087554
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2026-08-18
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.